Overview

Gender

male

Dr. Roos has 12 years of research and discovery experience, with more than five of those in biotechnology.

Prior to joining CalciMedica, Dr. Roos was Principal Scientist at TorreyPines Therapeutics. Dr. Roos, along with Dr. Stauderman, co-authored the discovery of STIM1, which has an essential role in CRAC channel activity and which is important for immune cell activation.

Dr. Roos has published over 20 peer-reviewed articles and reviews. Dr. Roos received his BA in Biochemistry and Cell Biology from UCSD, his PhD in Biochemistry and Molecular Biology from SUNY/Stony Brook and completed his postdoctoral studies in the Department of Biochemistry and Biophysics at UCSF.